VELA-101
/ Ursa Medicines
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 08, 2026
A Phase 1 Study of VELA-101 in Adult Participants
(clinicaltrials.gov)
- P1 | N=60 | Not yet recruiting | Sponsor: Ursa Medicines
First-in-human • New P1 trial • Dyslipidemia
1 to 1
Of
1
Go to page
1